Advancing Policy Initiatives: The Regulatory Policy Value of Drug and Device Companies' Participation in Trade Associations and Industry Consortia
Thursday, June 6, 2024
2:30 PM – 3:30 PM EDT
Location: Concourse B
This session explores the value of drug development and medical device companies' participation in trade associations and industry consortia, discussing how this collective influence can shape regulatory policy, provide strategic benefits, and maximize participation benefits, illustrated through examples and strategic insights.
Learning Objectives:
Understand key trade associations and consortia for medical devices, pharmaceuticals, and biologics.
Gain insights on considerations for participation in these organizations.
Evaluate approaches to advancing policy initiatives.
